However, since we show that IGFBP‐4 levels are reduced in fibroblasts from patients with SSc‐associated pulmonary fibrosis, it is likely that an imbalance of IGFBPs can contribute to the development of fibrosis. The gene discussed is IGFBP4; the disease is systemic sclerosis.